<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-050182</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cell saver devices in coronary revascularization surgery without extracorporeal circulation reduce transfusión requirements</dc:title>
<dc:description xml:lang="en">OBJECTIVES: To analyze the effectiveness of a cellsaver device in reducing transfusion requirements inpatients undergoing off-pump coronary artery bypasssurgery.PATIENTS AND METHODS: Fifty-six consecutive ASAclass 4-5 patients who underwent coronary surgery withoutextracorporeal circulation in our cardiac surgerydepartment between June 2004 and January 2005 wereincluded in this retrospective study; the series comprised28 patients who received conventional management(control group) without use of the cell saver deviceand 28 who received cell saver treatment. Variablesanalyzed were preoperative and discharge hemoglobinlevels and hematocrit values, age, weight, height, ejectionfraction, packed red blood cells transfused, exitus,and adverse events.RESULTS: The groups were similar with respect topreoperative characteristics. Fewer patients in the cellsaver group required transfusions (6 vs 18 in the controlgroup; relative risk 0.33, 95% confidence interval,0.16-0.71). The mean amount of packed red cells transfusedwas greater in the control group than in the cellsaver group (2.5 L vs 1.2 L, P=0.03). No deaths oradverse events occurred in either group.CONCLUSIONS: The routine use of a cell saver deviceduring off-pump coronary artery bypass surgery reducesthe need for postoperative transfusions and is notassociated with adverse events. Cell saver devicesshould be used routinely, especially in situations wherethe ability to provide blood transfusions may be compromised</dc:description>
<dc:creator>Ysasi, A</dc:creator>
<dc:creator>Trujillo, M. J</dc:creator>
<dc:creator>Llorens, R</dc:creator>
<dc:creator>Herreros, E</dc:creator>
<dc:creator>Tuesta, I. D</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">OBJETIVOS: Comprobar la eficacia en la reducción detransfusiones del recuperador celular en cirugía coronariaen pacientes que no se someten a circulación extracorpórea.PACIENTES Y MÉTODOS: 56 pacientes consecutivos conriesgo ASA III-IV operados desde junio de 2004 hastaenero de 2005 de cirugía coronaria sin circulación extracorpóreaen un Servicio de Cirugía Cardiaca. Estudioobservacional de cohortes retrospectivo. 28 pacientes(Grupo Control) fueron intervenidos de forma convencionalsin recuperador celular, y en 28 pacientes (GrupoEstudio) se empleó el recuperador celular (Cell Saver).Se determinó: Hemoglobina y Hematocrito preoperatoriosy al alta, edad, peso, talla, fracción de eyección, concentradosde hematíes trasfundidos, exitus y resultadosadversos.RESULTADOS: Las dos poblaciones han resultadohomogéneas en cuanto a criterios demográficos preoperatorios.En el grupo II (con recuperador) precisarontransfusiones menos pacientes (6 vs. 18, RR 0,33 IC 95%0,16-0,71). Se transfundieron más concentrados dehematíes de media en el grupo sin recuperador (2,5 vs1,2, p=0,03). No hubo exitus ni resultados adversos enninguno de los dos grupos.CONCLUSIONES: El uso rutinario de recuperador celularen cirugía coronaria sin bomba reduce las necesidadestransfusionales postoperatorias y no está asociadocon efectos adversos. Su empleo debe considerarse comoprocedimiento habitual de actuación, especialmente enmedios o situaciones en los que la disponibilidad de sangrepuede estar comprometida</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;53(8): 465-470, oct. 2006. tab, graf</dc:source>
<dc:identifier>ibc-050182</dc:identifier>
<dc:title xml:lang="es">El Recuperador Celular (Cell Saver) en cirugía de revascularización coronaria sin circulación extracorpórea reduce necesidades transfusionales</dc:title>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d7592^s22045</dc:subject>
<dc:subject>^d1832^s22045</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d28875</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d788^s22000</dc:subject>
<dc:subject>^d28232</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d28572</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200610</dc:date>
</metadata>
</record>
</ibecs-document>
